vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Stran & Company, Inc. (SWAG). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $28.9M, roughly 1.6× Stran & Company, Inc.). Stran & Company, Inc. runs the higher net margin — 0.8% vs -23.3%, a 24.1% gap on every dollar of revenue. On growth, Stran & Company, Inc. posted the faster year-over-year revenue change (7.2% vs 7.0%). Over the past eight quarters, Stran & Company, Inc.'s revenue compounded faster (24.0% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Stran & Company, Inc. provides branded promotional products, custom merchandise and integrated marketing solutions for corporate clients. It serves customers across retail, healthcare, technology, education and other sectors, supporting brand campaigns, customer engagement and employee incentive programs.

AMRN vs SWAG — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.6× larger
AMRN
$45.1M
$28.9M
SWAG
Growing faster (revenue YoY)
SWAG
SWAG
+0.2% gap
SWAG
7.2%
7.0%
AMRN
Higher net margin
SWAG
SWAG
24.1% more per $
SWAG
0.8%
-23.3%
AMRN
Faster 2-yr revenue CAGR
SWAG
SWAG
Annualised
SWAG
24.0%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
SWAG
SWAG
Revenue
$45.1M
$28.9M
Net Profit
$-10.5M
$243.0K
Gross Margin
30.4%
Operating Margin
35.5%
-0.1%
Net Margin
-23.3%
0.8%
Revenue YoY
7.0%
7.2%
Net Profit YoY
33.0%
141.5%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
SWAG
SWAG
Q1 26
$45.1M
Q4 25
$49.2M
$28.9M
Q3 25
$49.7M
$26.0M
Q2 25
$72.7M
$32.6M
Q1 25
$42.0M
$28.7M
Q4 24
$62.3M
$27.0M
Q3 24
$42.3M
$20.1M
Q2 24
$67.5M
$16.7M
Net Profit
AMRN
AMRN
SWAG
SWAG
Q1 26
$-10.5M
Q4 25
$-1.2M
$243.0K
Q3 25
$-7.7M
$-1.2M
Q2 25
$-14.1M
$643.0K
Q1 25
$-15.7M
$-393.0K
Q4 24
$-48.6M
$-586.0K
Q3 24
$-25.1M
$-2.0M
Q2 24
$1.5M
$-1.0M
Gross Margin
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
47.1%
30.4%
Q3 25
44.7%
27.2%
Q2 25
69.2%
30.3%
Q1 25
59.8%
29.6%
Q4 24
-15.4%
32.5%
Q3 24
38.5%
29.5%
Q2 24
63.4%
32.8%
Operating Margin
AMRN
AMRN
SWAG
SWAG
Q1 26
35.5%
Q4 25
-12.9%
-0.1%
Q3 25
-22.4%
-6.9%
Q2 25
-22.0%
1.2%
Q1 25
-39.9%
-1.9%
Q4 24
-84.3%
-3.5%
Q3 24
-59.5%
-10.8%
Q2 24
-0.8%
-6.6%
Net Margin
AMRN
AMRN
SWAG
SWAG
Q1 26
-23.3%
Q4 25
-2.5%
0.8%
Q3 25
-15.6%
-4.8%
Q2 25
-19.4%
2.0%
Q1 25
-37.4%
-1.4%
Q4 24
-78.0%
-2.2%
Q3 24
-59.4%
-10.1%
Q2 24
2.3%
-6.1%
EPS (diluted)
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
$0.00
$0.02
Q3 25
$-0.02
$-0.07
Q2 25
$-0.03
$0.03
Q1 25
$-0.04
$-0.02
Q4 24
$-0.12
$-0.02
Q3 24
$-0.06
$-0.11
Q2 24
$0.00
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
SWAG
SWAG
Cash + ST InvestmentsLiquidity on hand
$307.8M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$30.5M
Total Assets
$645.8M
$49.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
SWAG
SWAG
Q1 26
$307.8M
Q4 25
$302.6M
$11.6M
Q3 25
$286.6M
$11.8M
Q2 25
$298.7M
$18.1M
Q1 25
$281.8M
$12.2M
Q4 24
$294.2M
$18.2M
Q3 24
$305.7M
$6.9M
Q2 24
$306.7M
$9.6M
Stockholders' Equity
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
$459.3M
$30.5M
Q3 25
$458.9M
$30.2M
Q2 25
$464.9M
$31.8M
Q1 25
$473.7M
$31.3M
Q4 24
$486.2M
$31.6M
Q3 24
$531.4M
$32.3M
Q2 24
$551.9M
$34.3M
Total Assets
AMRN
AMRN
SWAG
SWAG
Q1 26
$645.8M
Q4 25
$670.8M
$49.3M
Q3 25
$659.8M
$50.3M
Q2 25
$670.1M
$61.2M
Q1 25
$655.7M
$52.2M
Q4 24
$685.3M
$55.1M
Q3 24
$750.6M
$48.8M
Q2 24
$799.9M
$46.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
SWAG
SWAG
Operating Cash FlowLast quarter
$161.0K
Free Cash FlowOCF − Capex
$38.0K
FCF MarginFCF / Revenue
0.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
0.66×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
$15.3M
$161.0K
Q3 25
$-12.7M
$-5.4M
Q2 25
$16.6M
$6.4M
Q1 25
$-12.5M
$-5.9M
Q4 24
$-13.3M
$1.3M
Q3 24
$-2.4M
$-2.7M
Q2 24
$-2.7M
$2.1M
Free Cash Flow
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
$38.0K
Q3 25
$-5.9M
Q2 25
$6.3M
Q1 25
$-6.0M
Q4 24
$1.2M
Q3 24
$-2.9M
Q2 24
$1.9M
FCF Margin
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
0.1%
Q3 25
-22.6%
Q2 25
19.5%
Q1 25
-21.0%
Q4 24
4.6%
Q3 24
-14.3%
Q2 24
11.6%
Capex Intensity
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
0.4%
Q3 25
1.9%
Q2 25
0.2%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.7%
Q2 24
1.1%
Cash Conversion
AMRN
AMRN
SWAG
SWAG
Q1 26
Q4 25
0.66×
Q3 25
Q2 25
9.99×
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

SWAG
SWAG

Promotional Products Dropshipping$11.2M39%
Casino Continuity Program$6.9M24%
Promotional Products Company Owned Inventory$4.6M16%
Promotional Products Bulk Dropshipping$3.8M13%
Promotional Products Thirdparty Distributor$1.8M6%
Other$610.0K2%

Related Comparisons